BARD1 only got the patent grant advice today, page-81

I feel that the issue at hand is the direction of the company. The company has recently stated that their direction is to develop their technology to become a test for other types of cancer. This shows the lack of understanding of shareholder needs by the directors of the company. This can take years. I feel as a potential future long term holder that it is necessary for the company to start to commercialise its technology to test for breast cancer to create revenue and a profitable business for its shareholders. Then it should use its profits to develop its technology to work with other cancer types. This will remove the likelihood that cash would need to be raised in the future and lead to significant share price appreciation.

I will consider entry once cash has been raised. (I got stopped out at B/E yesterday)